Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit
Investors who purchased shares of Pacira BioSciences, Inc. prior to August 2023 and continue to hold any of those NASDAQ: PCRX shares also have certain options and contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
On January 13, 2025, an investor in NASDAQ: PCRX shares filed a lawsuit over alleged violations of securities laws by Pacira BioSciences, Inc. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that defendants created the false impression that Pacira had sufficient patent protections on Exparel, and as such, the ability to expand the marketing, production, and sales of Exparel, which Pacira stated was critical to its future growth and revenue, that Pacira knew that the '495 patent was not as protective as Pacira publicly touted because on June 6, 2023, the United States District Court for the District of New Jersey issued a ruling in eVenus Pharmaceutical Laboratories, Inc.'s favor regarding claims construction in another case filed by Pacira in a failed attempt to protect Exparel, and that therefore, when the '495 patent was invalidated in another case Pacira filed against eVenus, investors and analysts alike were shocked by the concerning news that Exparel, which accounts for approximately 80% of Pacira's revenue, did not have sufficient patent protection to prevent another company from producing a generic during the life of the patent.
Those who purchased NASDAQ: PCRX shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
17 minutes ago
- The Star
Crypto firm Bitcoin Standard to list on Nasdaq through SPAC deal
FILE PHOTO: The Nasdaq logo is displayed at the Nasdaq stock market site in New York City, U.S., July 16, 2025. REUTERS/Kylie Cooper/File Photo
Free Malaysia Today
8 hours ago
- Free Malaysia Today
Nasdaq ends at another record high on Nvidia's China chip cheer
Nvidia, the leading AI chipmaker, drove the Nasdaq's rise with a 4% gain after announcing plans to resume H20 chip sales to China. (Reuters pic) NEW YORK : The Nasdaq Composite posted its latest record finish on Tuesday, supported by a jump in shares of heavyweight Nvidia, but the other Wall Street benchmarks dropped as a key inflation report and a flurry of bank earnings failed to excite investors. It was the fourth session in five that the technology-heavy Nasdaq index has posted a record close, and the eighth time since June 27. Artificial-intelligence chip leader Nvidia was the primary factor behind the Nasdaq's increase, gaining 4% after it unveiled plans to resume sales of its H20 AI chip to China. The news buoyed other chipmakers, with Advanced Micro Devices and Super Micro Computer both gaining more than 6.4%. The semiconductor index also advanced 1.3% to its highest point in a year, while the S&P technology index climbed by the same percentage to hit a record high. Rob Swanke, senior investment research analyst at Commonwealth Financial Network, said the Nvidia news meant that some investors, who had moved into other stocks due to technology's high valuations, were rotating back. 'I would probably say it's a one-day pop,' he added, noting that investors would be waiting for sales to be reflected in its earnings. The Nasdaq Composite gained 37.47 points, or 0.18%, to finish at 20,677.80. The Dow Jones Industrial Average fell 436.36 points, or 0.98%, to 44,023.29, and the S&P 500 lost 24.80 points, or 0.40%, to 6,243.76. Markets have been buoyant in recent weeks. Investor concerns that the US economy would be tarnished by President Donald Trump's policies, including major tariff announcements, have started to abate, allowing Wall Street to move higher. This week was expected to be a significant test of that improving sentiment, with the start of second-quarter earnings season and inflation reports that were forecast to reflect sellers starting to pass on higher tariff-related costs. The first of these reports showed US consumer prices posted their biggest jump in five months in June, hinting that tariffs may be starting to heat up inflation. Still, underlying inflation stayed moderate, offering some reassurance despite the headline spike. 'The picture from inflation this morning, coming in a little bit higher than expected but pretty much in line, gives you some sense that the tariffs are starting to flow through into the economy,' said Commonwealth's Swanke. 'We'll get more concrete news, as we go through earnings, to see how companies are delivering the impact of higher tariffs.' On the first day of second-quarter earnings season, banking stocks whipsawed in volatile trade. JPMorgan Chase slipped 0.7% despite raising its 2025 net interest income outlook, while Wells Fargo fell 5.5% even as its profit rose on reduced loan-loss reserves. BlackRock notched a new milestone for assets under management, yet its shares slid 5.9%. Bucking the trend, Citigroup climbed 3.7% to its highest finish since the global financial crisis, after its traders delivered a windfall that boosted second-quarter profit. The number of shares changing hands on US exchanges on Tuesday was 16.82 billion, compared with the 17.55 billion average for the last 20 trading days.
Free Malaysia Today
8 hours ago
- Free Malaysia Today
US stocks end higher, shrugging off Powell firing fears
Wall Street stocks finished higher with Nasdaq hitting a third straight record, while the Dow and S&P 500 also posted solid gains. (EPA Images pic) NEW YORK : Wall Street stocks finished higher Wednesday, shrugging off a mid-session swoon after US President Donald Trump denied plans to fire Federal Reserve Chair Jerome Powell. Major indices had moved suddenly negative following reports that a dismissal could be imminent. But they recovered quickly once Trump ruled out firing Powell, for now. Trump, who has bitterly attacked the Fed chair for months, said such a move was 'highly unlikely' and that 'I'm not talking about that' when asked if he would fire Powell. The tech-rich Nasdaq Composite Index advanced 0.3% to 20,730.49, a third straight closing record. The Dow Jones Industrial Average gained 0.5% to 44,254.78, while the broad-based S&P 500 advanced 0.3% to 6,263.70. 'It's very clear that the market wants to go higher,' said Adam Sarhan of 50 Park Investments, who described investor reaction to Trump's mixed messaging on Powell as typical of a bullish tilt. 'Every time we get bad news thrown at it, the market shrugs it off and continues to rally, including today,' Sarhan said. Otherwise, markets absorbed a generally benign wholesale inflation report. The producer price index was unchanged on a month-on-month basis, beating analysts' expectations and cooling from a 0.3 percent rise in May. The Fed's 'Beige Book' survey of economic conditions, however, pointed to growing impacts from Trump's myriad tariffs. Many firms said they passed along 'at least a portion of cost increases' to consumers due to tariffs, while also expressing expectations that costs will remain elevated. Among individual companies, Goldman Sachs jumped 0.8% after quarterly earnings easily topped analyst estimates. CEO David Solomon predicted an uptick in dealmaking, pointing to greater 'confidence level on the part of CEOs, that significant scaled industry consolidation is possible.' Ford slumped 2.9% after disclosing that it would account for US$570 million in costs connected to fuel injectors in several models from recent years, including Bronco Sport vehicles from 2021 to 2024. But Johnson & Johnson surged 6.2% as it lifted its full-year forecast after quarterly earnings topped estimates. Analysts noted that the health care company also lowered its estimate for the cost hit from tariffs.
